CB

Cynthia Bamdad

CEO

Minerva Biotechnologies

Boston, Massachusetts


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Minerva Biotechnologies
Industry
biotechnology
Employees
20.0
Seniority
C suite
Annual Revenue
7500000.0
Total Funding
41417135.0
Latest Funding
Other

Technologies

Outlook Microsoft Office 365 Google Maps Google Maps (Non Paid Users) Mobile Friendly Apache Typekit Google Analytics Render Remote

Keywords

cancer research immunooncology stem cell research regenerative medicine biotechnology life sciences cancer therapeutics immune oncology car t therapy muc1 targeting solid tumors cancer immunotherapy metastasis prevention stem cell therapy ipsc generation alphastem technology antibody-drug conjugates bispecific antibodies clinical trials cell-based therapies anti-cancer drugs chemo-resistance tumorigenesis extracellular domain t cell reprogramming metastatic growth factors nme7 antibody personalized medicine leukapheresis cancer immunotherapy clinical trials cancer stem cells growth factor receptors preclinical studies monoclonal antibodies tumor microenvironment cell differentiation protocols anti-muc1 antibodies immunotherapeutics cancer cell apoptosis immunomodulation immune escape mechanisms pharmaceutical collaborations biotechnology innovation therapeutic pipelines cell line development cancer biomarkers fda approved therapies clinical research bioengineering genetic modifications pharmacokinetics in vivo studies drug discovery analytical development health care health wellness & fitness hospital & health care

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans